Please enter keyword
OK
Please enter keyword
OK
English
Tumor-selective blockade of CD47 signaling with a CD47/PD-L1 bispecific antibody for enhanced anti-tumor activity and limited toxicity.
Time:2020-08-06

Used in this study: B-hCD47 mice

/Uploads/Picture/2022/10/25/u63578bf501fc8.pdf